{"blog": [], "keywords": [{"value": "Valeant Pharmaceuticals International Inc", "name": "organizations", "rank": "1", "is_major": "Y"}, {"value": "Pearson, John Michael (1959- )", "name": "persons", "rank": "2", "is_major": "Y"}, {"value": "Drugs (Pharmaceuticals)", "name": "subject", "rank": "3", "is_major": "Y"}, {"value": "United States Politics and Government", "name": "subject", "rank": "4", "is_major": "N"}, {"value": "Prices (Fares, Fees and Rates)", "name": "subject", "rank": "5", "is_major": "N"}, {"value": "Philidor Rx Services LLC", "name": "organizations", "rank": "6", "is_major": "N"}, {"value": "Senate Special Committee on Aging", "name": "organizations", "rank": "7", "is_major": "N"}, {"value": "Schiller, Howard B", "name": "persons", "rank": "8", "is_major": "N"}], "web_url": "http://www.nytimes.com/2016/04/28/business/valeant-pearson-ackman-hearing-congress-drug-prices.html", "document_type": "article", "byline": {"person": [{"lastname": "THOMAS", "firstname": "Katie", "role": "reported", "organization": "", "rank": 1}], "original": "By KATIE THOMAS"}, "type_of_material": "News", "multimedia": [{"url": "images/2016/04/28/business/28drug/28drug-thumbWide.jpg", "legacy": {"wide": "images/2016/04/28/business/28drug/28drug-thumbWide.jpg", "wideheight": "126", "widewidth": "190"}, "subtype": "wide", "type": "image", "width": 190, "height": 126}, {"url": "images/2016/04/28/business/28drug/28drug-articleLarge.jpg", "legacy": {"xlarge": "images/2016/04/28/business/28drug/28drug-articleLarge.jpg", "xlargeheight": "400", "xlargewidth": "600"}, "subtype": "xlarge", "type": "image", "width": 600, "height": 400}, {"url": "images/2016/04/28/business/28drug/28drug-thumbStandard.jpg", "legacy": {"thumbnail": "images/2016/04/28/business/28drug/28drug-thumbStandard.jpg", "thumbnailheight": "75", "thumbnailwidth": "75"}, "subtype": "thumbnail", "type": "image", "width": 75, "height": 75}], "section_name": "Business Day", "word_count": "1048", "source": "The New York Times", "subsection_name": null, "lead_paragraph": "\u201cIt was a mistake to pursue, and in hindsight I regret pursuing, transactions where a central premise was a planned increase in the prices of the medicines,\u201d J. Michael Pearson testified.", "pub_date": "2016-04-28T00:00:00Z", "news_desk": "Business", "headline": {"print_headline": "Valeant Made Pricing Mistakes, Chief Says", "main": "Valeant Chief, at Senate Hearing, Concedes Mistakes on Steep Drug Prices"}, "print_page": "1", "snippet": "\u201cIt was a mistake to pursue, and in hindsight I regret pursuing, transactions where a central premise was a planned increase in the prices of the medicines,\u201d J. Michael Pearson testified.", "_id": "5720ecce38f0d83acb9a5fa4", "slideshow_credits": null, "abstract": "Valeant Pharmaceuticals chief executive J Michael Pearson, at Senate hearing, says firm made mistakes regarding its practice of raising prices on old drugs. "}